WallStSmart
NRXP

NRX Pharmaceuticals Inc

NASDAQ: NRXP · HEALTHCARE · BIOTECHNOLOGY

$2.98
+2.41% today

Updated 2026-04-30

Market cap
$100.19M
P/E ratio
—
P/S ratio
81.79x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$2 – $4
Volume
0.9M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

NRX Pharmaceuticals Inc (NRXP) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item201720182019202020212022202320242025
Revenue———$0.00$0.00$0.00$0.00$0.00$1.23M
Revenue growth (YoY)—————————
Cost of revenue—$1.01M—$2000.00$2000.00$4000.00$5000.00$5000.00$648000.00
Gross profit—$-1.01M—$-2000.00$-2000.00$-4000.00$-5000.00$-5000.00$577000.00
Gross margin————————47.1%
R&D——$3495.00$10.63M$20.26M$17.03M$13.37M$6.20M$3.78M
SG&A$134480.00$1.01M$2767.00$11.44M$74.94M$27.37M$14.22M$13.51M$13.06M
Operating income$-134480.00$-1.01M$-713187.00$-22.06M$-95.20M$-44.34M$-27.59M$-19.70M$-16.22M
Operating margin————————-1324.4%
EBITDA$-105000.00$82412.00$492633.00$-51.72M$-93.04M$-39.75M$-30.02M$-24.04M$-16.04M
EBITDA margin————————-1309.8%
EBIT$-157516.00$-1.01M$-713187.00$-51.72M$-93.05M$-39.75M$-30.03M$-24.05M$-16.19M
Interest expense$0.00$0.00$0.00$56000.00$18000.00$4.58M$120000.00$1.08M$671000.00
Income tax—————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-105000.00$66101.00$408427.00$-51.78M$-93.06M$-39.75M$-30.15M$-25.13M$-28.62M
Net income growth (YoY)—+163.0%+517.9%-12777.2%-79.7%+57.3%+24.2%+16.7%-13.9%
Profit margin————————-2336.5%